
IQVIA Hlds (IQV) Stock Forecast & Price Target
IQVIA Hlds (IQV) Analyst Ratings
Bulls say
IQVIA Holdings has demonstrated strong year-over-year growth in its Functional Service Provider (FSP), Real World Evidence (RWE), and Contract Sales and Marketing Services (CSMS) segments, indicating robust demand across its service offerings. The company reported improved client decision timelines and a strong pipeline, driven by recent drug launches, which underlines positive momentum in its commercial business. Additionally, the improvement in the pricing environment and significant enhancement in the win rate, particularly in the Engagement and Business Performance (EBP) segment, reinforce the confidence in achieving a compound growth rate exceeding 4% on a constant currency basis, excluding COVID-19 impacts.
Bears say
The analysis indicates a negative outlook for IQVIA Holdings based on declining year-over-year revenue growth, which has decreased to 3.8% from 6.8% in the prior quarter, suggesting potential challenges in maintaining robust performance amid tough year-over-year comparisons. The company has expressed that it would be disappointed with revenue growth falling below 5% in 2026, which raises concerns about its ability to meet investor expectations amidst a backdrop of possible slowdown in Real-World Evidence (RWE) growth and reduced hiring due to attrition. Additionally, external factors such as rising interest rates may exert further downward pressure on earnings, compounding the concerns regarding operational productivity and margin impacts from passthroughs.
This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.
IQVIA Hlds (IQV) Analyst Forecast & Price Prediction
Start investing in IQVIA Hlds (IQV)
Order type
Buy in
Order amount
Est. shares
0 shares